AgroSpheres, Inc. and GreenLight Biosciences, Inc. have entered into a research collaboration to study the delivery of GreenLight’s double-stranded RNA (dsRNA) using AgroSpheres’ proprietary bioparticle platform. AgroSpheres’ platform consists of small, spherical bioparticles, lacking chromosomes that can encapsulate dsRNA and enhance its delivery for crop protection. The bioparticle can shield dsRNA from environmental conditions, including RNases that would otherwise degrade the dsRNA.
“GreenLight is an industry leader in high quality, low-cost production of RNA for a variety of agricultural applications. Our collaboration with GreenLight presents us with a unique opportunity to demonstrate the value of our platform for the delivery of biologicals,” said AgroSpheres’ CEO Doug Eisner.
“AgroSpheres’ encapsulation technology has the potential to enhance the delivery of our biocontrol platform for crop protection, which could open up additional uses for our highly specific, low toxicity class of products,” said Doug Boyes, GreenLight’s Director of Crop Protection Discovery.
GreenLight Biosciences, Inc. is a Medford, MA-based life sciences company committed to ensuring sustainable global development through the development of RNA-based products. GreenLight is currently developing RNA products for agricultural and health applications, and collaborating with industry leaders, to pave the way for advancements in vaccine development, pandemic preparation, crop management, and crop protection.
AgroSpheres, Inc. is a Charlottesville, VA based agricultural biotechnology company. AgroSpheres’ mission is to create products to enhance the delivery of crop protection products, making them safer and more environmentally friendly while also enhancing their efficacy. Co-founders, COO Payam Pourtaheri and CTO Ameer Shakeel developed AgroSpheres’ core technology while students at the University of Virginia in Charlottesville and formed AgroSpheres to commercialize their technology.